Senores Pharmaceuticals informs about disclosure
Senores Pharmaceuticals has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 04, 2025 for Renosen Pharmaceuticals.
The above information is a part of company’s filings submitted to BSE.
